12-21437854-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024854.5(PYROXD1):c.84+40C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.491 in 1,570,224 control chromosomes in the GnomAD database, including 189,640 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.49 ( 18583 hom., cov: 33)
Exomes 𝑓: 0.49 ( 171057 hom. )
Consequence
PYROXD1
NM_024854.5 intron
NM_024854.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.302
Genes affected
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 12-21437854-C-A is Benign according to our data. Variant chr12-21437854-C-A is described in ClinVar as [Benign]. Clinvar id is 1253388.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PYROXD1 | NM_024854.5 | c.84+40C>A | intron_variant | ENST00000240651.14 | |||
PYROXD1 | NM_001350913.2 | c.-620+40C>A | intron_variant | ||||
PYROXD1 | XM_006719153.4 | c.84+40C>A | intron_variant | ||||
PYROXD1 | XM_047429554.1 | c.84+40C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PYROXD1 | ENST00000240651.14 | c.84+40C>A | intron_variant | 1 | NM_024854.5 | P1 | |||
PYROXD1 | ENST00000544970.5 | c.84+40C>A | intron_variant, NMD_transcript_variant | 1 | |||||
PYROXD1 | ENST00000375266.8 | c.84+40C>A | intron_variant, NMD_transcript_variant | 5 | |||||
PYROXD1 | ENST00000543476.5 | c.84+40C>A | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.493 AC: 75014AN: 152040Hom.: 18563 Cov.: 33
GnomAD3 genomes
AF:
AC:
75014
AN:
152040
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.488 AC: 104479AN: 214048Hom.: 25398 AF XY: 0.487 AC XY: 56421AN XY: 115776
GnomAD3 exomes
AF:
AC:
104479
AN:
214048
Hom.:
AF XY:
AC XY:
56421
AN XY:
115776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.491 AC: 696339AN: 1418066Hom.: 171057 Cov.: 24 AF XY: 0.489 AC XY: 344841AN XY: 704620
GnomAD4 exome
AF:
AC:
696339
AN:
1418066
Hom.:
Cov.:
24
AF XY:
AC XY:
344841
AN XY:
704620
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.493 AC: 75080AN: 152158Hom.: 18583 Cov.: 33 AF XY: 0.492 AC XY: 36568AN XY: 74392
GnomAD4 genome
AF:
AC:
75080
AN:
152158
Hom.:
Cov.:
33
AF XY:
AC XY:
36568
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1931
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Myofibrillar myopathy 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at